The glomerular filter: an imperfect barrier is required for perfect renal function

Current Opinion in Nephrology and Hypertension

Volumn 18, Issue 4, 2009, Pages 336-342

  Comper, Wayne D ^a,b   Russo, Leileata M ^c  

^a MONASH UNIVERSITY   (Australia)

^b Exosome Diagnostics Inc   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Albumin retrieval pathway; albuminuria; glomerular charge; proximal tubular cell

Indexed keywords

ALBUMIN; CUBILIN; DYNAMIN; FC RECEPTOR; MEGALIN;

ACUTE KIDNEY TUBULE NECROSIS; ALBUMINURIA; GLOMERULAR STRUCTURE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; KIDNEY CLEARANCE; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; STREPTOZOCIN DIABETES;

ALBUMINS; ALBUMINURIA; ANIMALS; GLOMERULAR FILTRATION RATE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULAR NECROSIS, ACUTE; KIDNEY TUBULES, PROXIMAL; LYSOSOMES; RECEPTORS, ALBUMIN; RECEPTORS, FC;

EID: 67849113715     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32832cb96a     Document Type: Review

References (57)

1. Haraldsson B, Nyström J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008; 88:451-487. The traditional model of glomerular function and albuminuria is presented.
2. Tojo A, Endou H. Intrarenal handling of proteins in rats using fractional micropuncture technique. Am J Physiol 1992; 263:F601-F606.
3. Comper WD, Hilliard LM, Nikolic-Paterson D, Russo LM. Disease-dependent mechanisms of albuminuria. Am J Physiol Renal Physiol 2008; 295:F1589-F1600. A new model of PTC-controlled albuminuria is presented.
4. Comper WD, Osicka TM, Russo LM. Renal filtration, transport, and metabolism of albumin and albuminuria. In: Alpern R, Hebert S, editors. The kidney: physiology, pathophysiology. San Diego: Elsevier; 2007. pp. 2081-2112.
5. Vyas SV, Burne MJ, Pratt LM, Comper WD. Glomerular processing of dextran sulphate. Arch Biochem Biophys 1996; 332:205-212.
6. Chen S, Wassenhove-McCarthy DJ, Yamaguchi Y, et al. Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria. Kidney Int 2008; 74:289-299. Knockout mice that have halted heparan sulfate biosynthesis in podocytes do not develop significant albuminuria
7. Harvey SJ, Jarad G, Cunningham J, et al. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am J Pathol 2007; 171:139-152.
8. Rossi M, Morita H, Sormunen R, et al. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not the kidney. EMBO J 2003; 22:236-245.
9. van den Born J, Pisa B, Bakker MA, et al. No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy. J Biol Chem 2006; 281:29606-29613.
10. van den Hoven MJ, Wijnhoven TJ, Li JP, et al. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria. Kidney Int 2008; 73:278-287. Mice overexpressing heparanase resulting in a reduction of glycosaminoglycan anionic sites in the glomerular basement membrane are not albuminuric.
11. Goldberg S, Harvey SJ, Cunningham J, et al. Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane. Nephrol Dial Transplant 2009. [Epub ahead of print] Mice lacking the heparan sulfate chains of perlecan either alone or in combination with podocyte-specific loss of agrin were not proteinuric.
12. Adal Y, Smit MF, Osicka TM, Comper WD. Albumin interaction with the glomerular capillary wall in vitro. Kidney Int 1995; 47:1031-1038.
13. van den Hoven MJ, Rops AL, Vlodavsky I, et al. Heparanase in glomerular diseases. Kidney Int 2007; 72:543-548.
14. Williams KJ, Qiu G, Usui HK, et al. Decorin deficiency enhances progressive nephropathy in diabetic mice. Am J Pathol 2007; 171:1441-1450.
15. Ohlson M, Sörensson J, Lindström K, et al. Effects of filtration rate on the glomerular barrier and clearance of four differently shaped molecules. Am J Physiol 2001; 281:F103-F113.
16. Jeansson M, Björck K, Tenstad O, Haraldsson B. Adriamycin alters glomerular endothelium to induce proteinuria. J Am Soc Nephrol 2009; 20:114-122.
17. Jeansson M, Granqvist AB, Nyström JS, Haraldsson B. Functional and molecular alterations of the glomerular barrier in long-term diabetes. Diabetologia 2006; 49:2200-2209.
18. Jeansson M, Haraldsson B. Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. Am J Physiol Renal Physiol 2006; 290:F111-F116.
19. Lund U, Rippe A, Venturoli D, et al. Glomerular filtration rate dependence of sieving of albumin and some neutral proteins in rat kidneys. Am J Physiol Renal Physiol 2003; 284:F1226-F1234.
20. Rippe C, Rippe A, Torffvit O, Rippe B. Size and charge selectivity of the glomerular filter in early experimental diabetes in rats. Am J Physiol Renal Physiol 2007; 293:F1533-F1538.
21. Rippe C, Asgeirsson D, Venturoli D, et al. Effects of glomerular filtration rate on Ficoll sieving coefficients in rats. Kidney Int 2006; 69:1326-1332.
22. Venturoli D, Rippe B. Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am J Physiol Renal Physiol 2005; 288:F605-F613.
23. Fissell WH, Manley S, Dubnisheva A, et al. Ficoll is not a rigid sphere. Am J Physiol Renal Physiol 2007; 293:F1209-F1213.
24. Smit MF, Pratt LM, Comper WD. Conformational dependence of the fractional clearance of dextran and Ficoll. Nephrology 1996; 2:355-360.
25. Koltun M, Nikolovski J, Strong K, et al. Mechanism of hypoalbuminemia in rodents. Am J Physiol 2005; 288:H1604-H1610.
26. Saito H, Takahashi S, Nagata M, et al. Reevaluation of glomerular charge selective protein-sieving function. Pediatr Nephrol 2009; 24:609-612.
27. Russo LM, Sandoval RM, McKee M, et al. The normal kidney filters nephrotic levels of albumin that is retrieved by the proximal tubule cell: retrieval is disrupted in nephrotic states. Kidney Int 2007; 71:504-513.
28. Gekle M. Renal albumin handling: a look at the dark side of the filter. Kidney Int 2007; 71:479-481.
29. Russo LM, Sandoval RM, McKee M, et al. Albuminuria in diabetes is due to dysfunction of proximal tubular cell processing and not changes in albumin filtration. J Am Soc Nephrol 2009; 20:489-494. Glomerular permeability measured directly by two-photon microscopy in the diabetic rat remains unaltered.
30. Asgeirsson D, Venturoli D, Fries E, et al. Glomerular sieving of three neutral polysaccharides, polyethylene oxide and bikunin in rat. Effects of molecular size and conformation. Acta Physiol 2007; 191:237-246.
31. Tanner GA. Glomerular sieving coefficient of serum albumin in the rat: a two- photon microscopy study. Am J Physiol Renal Physiol 2009. [Epub ahead of print] The methodological problems are exemplified by the following major discrepancy in the Tanner et al. data. Originally, Tanner et al. found GSCs for albumin in the Necturus of 0.03 (Tanner et al. J Am Soc Nephrol 2004; 15:211A). They then published another paper (Tanner et al, Am J Physiol Renal Physiol 2009 [Epub ahead of print]) stating that GSCs were originally too high due to possible contaminants and they obtained low GSCs. The high GSC data were then eliminated. Yet in this publication, Tanner demonstrated that the albumin preparations used in the Necturus study had no contaminants.
32. Ryan GB, Karnovsky MJ. Distribution of endogenous albumin in the rat glomerulus: role of hemodynamic factors in glomerular barrier function. Kidney Int 1976; 9:36-45.
33. Jarad G, Miner JH. Albuminuria, wherefore art thou? J Am Soc Nephrol 2009; 20:455-457.
34. Birn H, Christensen EI. Renal albumin absorption in physiology and pathology. Kidney Int 2006; 69:440-449.
35. Eppel GA, Osicka TM, Pratt LM, et al. The return of glomerular filtered albumin to the rat renal vein. Kidney Int 1999; 55:1861-1870.
36. Hilliard LM, Osicka TM, Clavant S, et al. Characterisation of the urinary albumin degradation pathway in the isolated perfused rat kidney. J Lab Clin Med 2006; 147:36-44.
37. Hilliard LM, Russo LM, Comper WD. Insights into the relationship between hypertension and albuminuria. Curr Hypertens Rev 2007; 3:29-37.
38. Hilliard LM, Russo LM, Comper WD. Albuminuria in cardiovascular disease is associated with reduced lysosomal activity in the kidney and the heart. Am J Nephrol 2009; 29:454-464. This paper describes a plausible relationship of why cardiovascular disease is associated with albuminuria.
39. Park CH, Maack T. Albumin absorption and catabolism by isolated perfused proximal convoluted tubules of the rabbit. J Clin Invest 1984; 73:767-777.
40. Clavant SP, Comper WD. Urinary clearance of albumin is critically determined by its tertiary structure. J Lab Clin Med 2003; 142:372-384.
41. Osicka TM, Pratt LM, Comper WD. Glomerular capillary wall permeability to albumin and horseradish peroxidase. Nephrology 1996; 2:199-212.
42. Chaudhury C, Brooks CL, Carter DC, et al. Albumin binding to FcRn: distinct from the FcRn-IgG interaction. Biochemistry 2006; 45:4983-4990.
43. Chaudhury C, Mehnaz S, Robinson JM, et al. The major histocompatibility complex-related Fcreceptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 2003; 197:315-322.
44. Sarav M, Wang Y, Hack BK, et al. The handling of albumin and IgG by FcRn is distinct in renal and extrarenal sites. J Am Soc Nephrol (in press). This intriguing paper suggests that the retrieval pathway is associated with the FcRn receptor in the PTC.
45. He W, Ladinsky MS, Huey-Tubman KE, et al. FcRn-mediated antibody transport across epithelial cells revealed by electron tomography. Nature 2008; 455:542-546. Transcellular transport of proteins in epithelial cells is observed in this study.
46. Kantarci S, Al-Gazali L, Hill RS, et al. Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes. Nat Gen 2007; 39:957-959.
47. Leheste JR, Melsen F, Wellner M, et al. Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J 2003; 17:247-249.
48. Birn H, Fyfe JC, Jacobsen C, et al. Cubilin is an albumin binding protein important for renal tubular reabsorption. J Clin Invest 2000; 105:1354-1361.
49. Myers BD, Winetz JA, Chui F, Michaels AS. Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function. Kidney Int 1982; 21:633-641.
50. Scandling JD, Black VM, Deen WM, Myers BD. Glomerular permselectivity in healthy and nephrotic humans. Adv Nephrol 1992; 21:159-176.
51. Greive KA, Nikolic-Paterson DJ, Guimarães MAM, et al. Glomerular perm- selectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis. Am J Pathol 2001; 159:1159-1170.
52. Faul C, Donnelly M, Merscher-Gomez S, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nature Med 2008; 14:931-938.
53. Wei C, Möller C, Altintas MM, et al. Modification of kidney barrier function by the urokinase receptor. Nat Med 2008; 14:55-62.
54. Comper WD. Is the LPS-mediated proteinuria mouse model relevant to human kidney disease? Nat Med 2009; 15:133.
55. Russo LM, del Re E, Brown D, Lin HY. Evidence for a role of transforming growth factor (TGF)-b1 in the induction of postglomerular albuminuria in diabetic nephropathy. Diabetes 2007; 56:380-388.
56. Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006; 354:1387-1401.
57. Koltun M, Comper WD. Retention of albumin in the circulation is governed by saturable renal cell-mediated processes. Microcirculation 2004; 11:351-360.